Building Iowa's Future, Board of Regents Annual Report, 2012

This report is the annual report for the Board of Regents.

Student Strong, Iowa Proud, Board of Regents Annual Report, 2014

This report is the annual report for the Board of Regents.

Excellence to Innovation, Board of Regents Annual Report, 2013

This report is the annual report for the Board of Regents.

Iowa Board of Nursing Newsletter, February, March, April 2015 Vol. 34, no. 1

Newsletter produced by the Iowa Board of Nursing for nurses to keep them informed to CE classes, renewals, board meetings, etc. Produced 4 times a year. Also known as Nursing Newsletter.

Iowa Board of Parole Annual Report, 2004

Annual report produced by Iowa Board of Parole

Iowa Board of Parole Annual Report, 2005

Annual report produced by Iowa Board of Parole

Iowa Board of Parole Annual Report, 2006

Annual report produced by Iowa Board of Parole

Iowa Board of Parole Annual Report for State Fiscal Year 2008 (July 1, 2007 – June 30, 2008), January 20, 2009

Annual report produced by Iowa Board of Parole

Iowa Board of Parole Annual Report for State Fiscal Year 2010 (July 1, 2009 – June 30, 2010) January 18, 2011

Annual report produced by Iowa Board of Parole

Iowa Board of Parole Annual Report for State Fiscal Year 2011 (July 1, 2010 – June 30, 2011) January 3, 2012

Annual report produced by Iowa Board of Parole

Iowa Board of Parole Annual Report for State Fiscal Year 2012, March 29, 2013

Annual report produced by Iowa Board of Parole

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

PURPOSE: The European Organisation for Research and Treatment of Cancer and National Cancer Institute of Canada trial on temozolomide (TMZ) and radiotherapy (RT) in glioblastoma (GBM) has demonstrated that the combination of TMZ and RT conferred a significant and meaningful survival advantage compared with RT alone. We evaluated in this trial whether the recursive partitioning analysis (RPA) retains its overall prognostic value and what the benefit of the combined modality is in each RPA class. PATIENTS AND METHODS: Five hundred seventy-three patients with newly diagnosed GBM were randomly assigned to standard postoperative RT or to the same RT with concomitant TMZ followed by adjuvant TMZ. The primary end point was overall survival. The European Organisation for Research and Treatment of Cancer RPA used accounts for age, WHO performance status, extent of surgery, and the Mini-Mental Status Examination. RESULTS: Overall survival was statistically different among RPA classes III, IV, and V, with median survival times of 17, 15, and 10 months, respectively, and 2-year survival rates of 32%, 19%, and 11%, respectively (P < .0001). Survival with combined TMZ/RT was higher in RPA class III, with 21 months median survival time and a 43% 2-year survival rate, versus 15 months and 20% for RT alone (P = .006). In RPA class IV, the survival advantage remained significant, with median survival times of 16 v 13 months, respectively, and 2-year survival rates of 28% v 11%, respectively (P = .0001). In RPA class V, however, the survival advantage of RT/TMZ was of borderline significance (P = .054). CONCLUSION: RPA retains its prognostic significance overall as well as in patients receiving RT with or without TMZ for newly diagnosed GBM, particularly in classes III and IV.

2015 Annual Report of the Iowa Board of Medicine, April 11, 2016

This is a summary of some of the activities the Board was involved with in 2011. More information about the Board’s work is available in the agendas, minutes, reports and press releases on the website, www.medicalboard.iowa.gov, and the Board’s page on Facebook. Much has been accomplished in the past year, but much more remains to be done. The Board looks forward to the many challenges that lie ahead and will continue to strengthen and enhance services to the public and licensees. I am very proud of the staff and Board members and their commitment to excellent service to the citizens of Iowa.

Iowa Board of Nursing Annual Report, July 1, 2014-June 30, 2015

The annual report of the Iowa Board of Nursing includes information on legislation, administrative rules, nursing education, nursing practice, continuing education, licensing, enforcement, administration, financial report, statistics and general nursing demographics.

Iowa Board of Nursing Summary of Annual Report, July 1, 2014-June 30, 2015

The annual report of the Iowa Board of Nursing includes information on legislation, administrative rules, nursing education, nursing practice, continuing education, licensing, enforcement, administration, financial report, statistics and general nursing demographics.